My ePortfolio Register   

WIN Symposium 2017 /
Bayesian adaptive trial designs for precision medicine

26th - 27th Jun 2017

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 04.07.17
Views: 514

Dr Jack Lee - MD Anderson Cancer Center, Houston, USA

Dr Lee speaks with ecancer at WIN 2017 about changing attitudes and designs of trial design to a Bayesian framework, which integrates serial data collection into the assessment of patient response.

He notes 20% of trials conducted at M.D. Anderson incorporate some elements of Bayesian design, including the I-SPY 2 trial, discussed at AACR 2016.

The statistics software discussed by Dr Lee is available here

Trial design is also discussed by Dr Razelle Kurzrock, here.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence